↓ Skip to main content

Zonisamide add-on for drug-resistant partial epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Zonisamide add-on for drug-resistant partial epilepsy
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd001416.pub3
Pubmed ID
Authors

Katie Carmichael, Jennifer Pulman, Shaheen Emmanuel Lakhan, Prachi Parikh, Anthony G Marson

Abstract

The majority of people with epilepsy have a good prognosis and their seizures can be well controlled with the use of a single antiepileptic agent, but up to 30% develop refractory epilepsy, especially those with partial seizures. In this review we summarise the current evidence regarding zonisamide, when used as an add-on treatment for drug-resistant partial epilepsy.

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
United States 1 3%
Russia 1 3%
Italy 1 3%
Unknown 27 87%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 19%
Student > Master 5 16%
Student > Postgraduate 3 10%
Student > Bachelor 3 10%
Professor 2 6%
Other 9 29%
Unknown 3 10%
Readers by discipline Count As %
Medicine and Dentistry 17 55%
Psychology 3 10%
Nursing and Health Professions 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Business, Management and Accounting 1 3%
Other 3 10%
Unknown 4 13%